Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Cosopt versus Xalacom for diurnal intraocular pressure control
2005-006005-61Phase 4Completed
- Sponsor
- PRN Pharmaceutical Research Network
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dorzolamide and timolol in open-angle glaucoma (OAG), pseudoexfoliation glaucoma (PXG), pigmentary glaucoma (PG) and 1 more (2 arms), sponsored by PRN Pharmaceutical Research Network. Primary endpoint: Diurnal intraocular pressure (12 hours). Started Mar 2006; status: completed.
02
Drugs
dorzolamidetimolol
03
Conditions
open-angle glaucoma (OAG)pseudoexfoliation glaucoma (PXG)pigmentary glaucoma (PG)ocular hypertension
Beyond the preview
Go deeper on 2005-006005-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-006005-61.